1	Impaired	impaired	_	_	_	_	_	_	_
2	induction	induction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	c-fos/c-jun	c-fos/c-jun	_	_	_	_	_	_	_
5	genes	gene	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	transcriptional	transcriptional	_	_	_	_	_	_	_
9	regulatory	regulatory	_	_	_	_	_	_	_
10	proteins	protein	_	_	_	_	_	_	_
11	binding	bind	_	_	_	_	_	_	_
12	distinct	distinct	_	_	_	_	_	_	_
13	c-fos/c-jun	c-fos/c-jun	_	_	_	_	_	_	_
14	promoter	promoter	_	_	_	_	_	_	_
15	elements	element	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	activated	activate	_	_	_	_	_	_	_
18	human	human	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	during	during	_	_	_	_	_	_	_
22	aging	aging	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	transcriptional	transcriptional	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	c-Fos/c-Jun	c-fos/c-jun	_	_	_	_	_	_	_
7	AP-1	ap-1	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	essential	essential	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	normal	normal	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	responsiveness	responsiveness	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	often	often	_	_	_	_	_	_	_
18	impaired	impaired	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	during	during	_	_	_	_	_	_	_
23	aging	aging	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	present	present	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	we	we	_	_	_	_	_	_	_
7	investigated	investigate	_	_	_	_	_	_	_
8	whether	whether	_	_	_	_	_	_	_
9	aberrancies	aberrancy	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	regulation	regulation	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	c-fos/c-jun	c-fos/c-jun	_	_	_	_	_	_	_
15	at	at	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	mRNA	mrna	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	protein	protein	_	_	_	_	_	_	_
20	level	level	_	_	_	_	_	_	_
21	might	might	_	_	_	_	_	_	_
22	underlie	underlie	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	age-associated	age-associated	_	_	_	_	_	_	_
25	impairments	impairment	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	AP-1	ap-1	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	human	human	_	_	_	_	_	_	_
30	T	t	_	_	_	_	_	_	_
31	cells	cell	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Whereas	whereas	_	_	_	_	_	_	_
2	T	t	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	young	young	_	_	_	_	_	_	_
6	subjects	subject	_	_	_	_	_	_	_
7	stimulated	stimulate	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	cross-linked	cross-linked	_	_	_	_	_	_	_
10	anti-CD3epsilon	anti-cd3epsilon	_	_	_	_	_	_	_
11	mAb	mab	_	_	_	_	_	_	_
12	OKT3	OKT3	_	_	_	_	_	_	_
13	plus	plus	_	_	_	_	_	_	_
14	PMA	PMA	_	_	_	_	_	_	_
15	or	or	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	lectin	lectin	_	_	_	_	_	_	_
19	PHA	PHA	_	_	_	_	_	_	_
20	plus	plus	_	_	_	_	_	_	_
21	PMA	PMA	_	_	_	_	_	_	_
22	demonstrated	demonstrate	_	_	_	_	_	_	_
23	considerable	considerable	_	_	_	_	_	_	_
24	increases	increase	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	c-Fos	c-fos	_	_	_	_	_	_	_
27	protein	protein	_	_	_	_	_	_	_
28	expression	expression	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	expression	expression	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	c-Fos	c-fos	_	_	_	_	_	_	_
34	but	but	_	_	_	_	_	_	_
35	not	not	_	_	_	_	_	_	_
36	c-Jun	c-jun	_	_	_	_	_	_	_
37	was	be	_	_	_	_	_	_	_
38	markedly	markedly	_	_	_	_	_	_	_
39	reduced	reduce	_	_	_	_	_	_	_
40	in	in	_	_	_	_	_	_	_
41	stimulated	stimulate	_	_	_	_	_	_	_
42	T	t	_	_	_	_	_	_	_
43	cells	cell	_	_	_	_	_	_	_
44	from	from	_	_	_	_	_	_	_
45	certain	certain	_	_	_	_	_	_	_
46	elderly	elderly	_	_	_	_	_	_	_
47	subjects	subject	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	RNase	RNase	_	_	_	_	_	_	_
5	protection	protection	_	_	_	_	_	_	_
6	assays	assay	_	_	_	_	_	_	_
7	revealed	reveal	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	anti-CD3/PMA-stimulated	anti-cd3/pma-stimulated	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	from	from	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	substantial	substantial	_	_	_	_	_	_	_
15	proportion	proportion	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	elderly	elderly	_	_	_	_	_	_	_
18	subjects	subject	_	_	_	_	_	_	_
19	exhibited	exhibit	_	_	_	_	_	_	_
20	decreased	decrease	_	_	_	_	_	_	_
21	levels	level	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	c-fos	c-fos	_	_	_	_	_	_	_
24	and/or	and/or	_	_	_	_	_	_	_
25	c-jun	c-jun	_	_	_	_	_	_	_
26	mRNA	mrna	_	_	_	_	_	_	_
27	compared	compare	_	_	_	_	_	_	_
28	to	to	_	_	_	_	_	_	_
29	T	t	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	from	from	_	_	_	_	_	_	_
32	young	young	_	_	_	_	_	_	_
33	subjects	subject	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	electrophoretic	electrophoretic	_	_	_	_	_	_	_
3	mobility	mobility	_	_	_	_	_	_	_
4	shift	shift	_	_	_	_	_	_	_
5	assays	assay	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	levels	level	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	nuclear	nuclear	_	_	_	_	_	_	_
11	regulatory	regulatory	_	_	_	_	_	_	_
12	proteins	protein	_	_	_	_	_	_	_
13	recognizing	recognize	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	AP-1	ap-1	_	_	_	_	_	_	_
16	consensus	consensus	_	_	_	_	_	_	_
17	TRE	tre	_	_	_	_	_	_	_
18	motif	motif	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	proximal	proximal	_	_	_	_	_	_	_
22	c-jun	c-jun	_	_	_	_	_	_	_
23	TRE-like	tre-like	_	_	_	_	_	_	_
24	promoter	promoter	_	_	_	_	_	_	_
25	element	element	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	c-fos	c-fos	_	_	_	_	_	_	_
30	serum	serum	_	_	_	_	_	_	_
31	response	response	_	_	_	_	_	_	_
32	element	element	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	SRE	SRE	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	were	be	_	_	_	_	_	_	_
37	determined	determine	_	_	_	_	_	_	_
38	in	in	_	_	_	_	_	_	_
39	resting	rest	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	stimulated	stimulate	_	_	_	_	_	_	_
42	T	t	_	_	_	_	_	_	_
43	cells	cell	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	stimulation	stimulation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	from	from	_	_	_	_	_	_	_
8	young	young	_	_	_	_	_	_	_
9	subjects	subject	_	_	_	_	_	_	_
10	resulted	result	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	coordinated	coordinate	_	_	_	_	_	_	_
13	increases	increase	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	nuclear	nuclear	_	_	_	_	_	_	_
16	protein	protein	_	_	_	_	_	_	_
17	complexes	complex	_	_	_	_	_	_	_
18	binding	bind	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	AP-1	ap-1	_	_	_	_	_	_	_
21	TRE	tre	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	c-jun	c-jun	_	_	_	_	_	_	_
24	TRE	tre	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	c-fos	c-fos	_	_	_	_	_	_	_
28	SRE	SRE	_	_	_	_	_	_	_
29	DNA	DNA	_	_	_	_	_	_	_
30	sequence	sequence	_	_	_	_	_	_	_
31	motifs	motif	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	age-related	age-related	_	_	_	_	_	_	_
34	reductions	reduction	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	activation	activation	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	AP-1	ap-1	_	_	_	_	_	_	_
40	were	be	_	_	_	_	_	_	_
41	accompanied	accompany	_	_	_	_	_	_	_
42	by	by	_	_	_	_	_	_	_
43	decreased	decrease	_	_	_	_	_	_	_
44	levels	level	_	_	_	_	_	_	_
45	of	of	_	_	_	_	_	_	_
46	c-jun	c-jun	_	_	_	_	_	_	_
47	TRE	tre	_	_	_	_	_	_	_
48	and	and	_	_	_	_	_	_	_
49	c-fos	c-fos	_	_	_	_	_	_	_
50	SRE	sre	_	_	_	_	_	_	_
51	binding	binding	_	_	_	_	_	_	_
52	complexes	complex	_	_	_	_	_	_	_
53	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	complexes	complex	_	_	_	_	_	_	_
7	binding	bind	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	SRE	SRE	_	_	_	_	_	_	_
10	motif	motif	_	_	_	_	_	_	_
11	induced	induce	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	activated	activate	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	young	young	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	elderly	elderly	_	_	_	_	_	_	_
20	subjects	subject	_	_	_	_	_	_	_
21	contained	contain	_	_	_	_	_	_	_
22	serum	serum	_	_	_	_	_	_	_
23	response	response	_	_	_	_	_	_	_
24	factor	factor	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	Elk-1	elk-1	_	_	_	_	_	_	_
27	pointing	pointing	_	_	_	_	_	_	_
28	toward	toward	_	_	_	_	_	_	_
29	age-related	age-related	_	_	_	_	_	_	_
30	defects	defect	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	activation	activation	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	transcriptional	transcriptional	_	_	_	_	_	_	_
36	regulatory	regulatory	_	_	_	_	_	_	_
37	proteins	protein	_	_	_	_	_	_	_
38	distinct	distinct	_	_	_	_	_	_	_
39	from	from	_	_	_	_	_	_	_
40	c-jun/AP-1	c-jun/ap-1	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	underlying	underlie	_	_	_	_	_	_	_
6	aberrancies	aberrancy	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	induction	induction	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	c-fos/c-jun	c-fos/c-jun	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	well	well	_	_	_	_	_	_	_
14	as	as	_	_	_	_	_	_	_
15	their	their	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	regulatory	regulatory	_	_	_	_	_	_	_
18	proteins	protein	_	_	_	_	_	_	_
19	may	may	_	_	_	_	_	_	_
20	contribute	contribute	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	age-related	age-related	_	_	_	_	_	_	_
24	impairments	impairment	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	AP-1	ap-1	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	human	human	_	_	_	_	_	_	_
30	T	t	_	_	_	_	_	_	_
31	cells	cell	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

